Royal Bank of Canada’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.94M | Buy |
|
|||||
|
2025
Q2 | $1.43M | Buy |
|
|||||
|
2025
Q1 | $1.76M | Buy |
|
|||||
|
2024
Q4 | $652K | Sell |
|
|||||
|
2024
Q3 | $739K | Sell |
|
|||||
|
2024
Q2 | $5.25M | Sell |
|
|||||
|
2024
Q1 | $4.72M | Buy |
|
|||||
|
2023
Q4 | $845K | Buy |
|
|||||
|
2023
Q3 | $402K | Buy |
|
|||||
|
2023
Q2 | $167K | Sell |
|
|||||
|
2023
Q1 | $552K | Buy |
|
|||||
|
2022
Q4 | $448K | Buy |
|
|||||
|
2022
Q3 | $184K | Sell |
|
|||||
|
2022
Q2 | $340K | Buy |
|
|||||
|
2022
Q1 | $156K | Sell |
|
|||||
|
2021
Q4 | $373K | Sell |
|
|||||
|
2021
Q3 | $1.31M | Sell |
|
|||||
|
2021
Q2 | $1.56M | Sell |
|
|||||
|
2021
Q1 | $1.86M | Sell |
|
|||||
|
2020
Q4 | $3.69M | Sell |
|
|||||
|
2020
Q3 | $3.5M | Sell |
|
|||||
|
2020
Q2 | $3.52M | Buy |
|
|||||
|
2020
Q1 | $2.49M | Buy |
|
|||||
|
2019
Q4 | $440K | Buy |
|
|||||
|
2019
Q3 | $510K | Sell |
|
|||||
|
2019
Q2 | $404K | Buy |
|
|||||
|
2019
Q1 | $283K | Sell |
|
|||||
|
2018
Q4 | $474K | Sell |
|
|||||
|
2018
Q3 | $535K | Buy |
|
|||||
|
2018
Q2 | $16K | Sell |
|
|||||
|
2018
Q1 | $19K | Sell |
|
|||||
|
2017
Q4 | $25K | Sell |
|
|||||
|
2017
Q3 | $505K | Buy |
|
|||||
|
2017
Q2 | $264K | Buy |
|
|||||
|
2017
Q1 | $138K | Sell |
|
|||||
|
2016
Q4 | $301K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1K | Sell |
|
|||||
|
2015
Q3 | $11K | Buy |
|
|||||
|
2015
Q2 | $18K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $2K | Hold |
|
|||||
|
2013
Q4 | $1K | Hold |
|
|||||
|
2013
Q3 | $1K | Buy |
|